a public good project by the
Synthesis
Company
of California

© 2026

Nan‐Horng Lin | doi.page

0 works0 citations0 h-index

Nan‐Horng Lin

City University of Hong Kong(HK)City University of Hong Kong, Shenzhen Research Institute(CN)

Publications by Year

Research Areas

Nicotinic Acetylcholine Receptors Study, Cholinesterase and Neurodegenerative Diseases, Cancer-related Molecular Pathways, DNA Repair Mechanisms, Cancer therapeutics and mechanisms

Most-Cited Works

→ Novel 3-Pyridyl Ethers with Subnanomolar Affinity for Central Neuronal Nicotinic Acetylcholine Receptors(1996)231 cited
→ A common glycan structure on immunoglobulin G for enhancement of effector functions(2015)204 cited
→ Identification and Initial Structure−Activity Relationships of (R)-5-(2-Azetidinylmethoxy)-2-chloropyridine (ABT-594), a Potent, Orally Active, Non-Opiate Analgesic Agent Acting via Neuronal Nicotinic Acetylcholine Receptors(1998)131 cited
→ Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics(2006)129 cited
→ Chk1 Inhibitors for Novel Cancer Treatment(2006)92 cited
→ Structure-Based Design, Synthesis, and Biological Evaluation of Potent and Selective Macrocyclic Checkpoint Kinase 1 Inhibitors(2007)88 cited

→ Discovery of 3H-Benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective, and Orally Bioavailable Inhibitors of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia Virus (PIM) Kinases(2009)

84 cited

→ Synthesis and Evaluation of Nicotine Analogs as Neuronal Nicotinic Acetylcholine Receptor Ligands(1994)80 cited

→ ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A Potent and Selective Cholinergic Channel Modulator with Neuroprotective Properties(1997)78 cited

→ ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: A Novel, Orally Effective Antinociceptive Agent Acting via Neuronal Nicotinic Acetylcholine Receptors: II. In Vivo Characterization(1998)77 cited